Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to...
large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
...
Next
(77)
•••
Pareto8020
X
View Profile
View Bullboard History
Comment by
Pareto8020
on Oct 21, 2023 9:41am
RE:RE:RE:New Press Release - Sirona Biochem Announces Payment of Convertible Debenture Interests in Shares
Can't wait to see how biorun spins this as a positive? At every turn Howard makes the wrong decision and guides this ship onto the rocks. Let us look at some highlights
...more
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Oct 21, 2023 1:00am
RE:RE:New Press Release - Sirona Biochem Announces Payment of Convertible Debenture Interests in Shares
Howie has no money anymore and has to pay loan interest with all time low shares. Dismal. So much for non diluted financing. These guys are worthless.
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(2138)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Oct 20, 2023 11:40pm
RE:New Press Release - Sirona Biochem Announces Payment of Convertible Debenture Interests in Shares
No way these bozos voluntarily agreed to an upfront payment of only $500,000 US.
(1167)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Oct 20, 2023 6:15pm
RE:RE:New Press Release - Sirona Biochem Announces Payment of Convertible Debenture Interests in Shares
It was in the news release back in April: "The Principal of the Debenture Units will accrue interest at a rate of 12% per annum, which accrued interest (“Accrued Interest”) will be paid semi
...more
(16)
•••
moneycollector
X
View Profile
View Bullboard History
Comment by
moneycollector
on Oct 20, 2023 5:31pm
RE:RE:New Press Release - Sirona Biochem Announces Payment of Convertible Debenture Interests in Shares
Can you see the smile in my face?
(1167)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Oct 20, 2023 5:02pm
RE:New Press Release - Sirona Biochem Announces Payment of Convertible Debenture Interests in Shares
Is that what you describe as a "Friday after the market is closed" type of news release?
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 20, 2023 4:50pm
New Press Release - Sirona Biochem Announces Payment of Convertible Debenture Interests in Shares
NOTFORDISSEMINATIONIN THEUSORTHROUGH USNEWSWIRESERVICES VANCOUVER, British Columbia, Oct. 20, 2023 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona” or the “Company”) announces that pursuant to the 12% unsecured, convertible debentures in the principal...
read article.
(2104)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Oct 19, 2023 3:35pm
RE:RE:RE:RE:RE:RE:CYCLIC GLYCOAMINOACID DERIVATIVES
" this is supposed to be a community of like minded investors " bioruns, it is, and but for you, everyone is pizzed right off at the utter failure of SBM to get anything to market
...more
(1167)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Oct 19, 2023 12:47pm
RE:RE:RE:CYCLIC GLYCOAMINOACID DERIVATIVES
It's just sitting in limbo in the USPTO for over a year. Nobody appears to be pushing it. Documents
...more
(77)
•••
Pareto8020
X
View Profile
View Bullboard History
Comment by
Pareto8020
on Oct 19, 2023 12:18pm
RE:RE:RE:RE:CYCLIC GLYCOAMINOACID DERIVATIVES
This is such a dead duck right now. No sales, trial results, news, staff updates, promo or partnerships. The sad state of affairs clearly rests with the leader who is still in denial of his
...more
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Oct 19, 2023 12:01pm
RE:RE:RE:RE:RE:CYCLIC GLYCOAMINOACID DERIVATIVES
Ok Don/Dave/Richard/Tyler, we don't need to put people through this. The facts are that the patent filing on Anti aging is happening in a multitude of regions and countries around the world
...more
(2104)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Oct 19, 2023 9:53am
RE:RE:RE:RE:CYCLIC GLYCOAMINOACID DERIVATIVES
You have to give biorun credit for always being optimistic even while being 100% wrong 100% of the time. It takes a "special" person to keep that up for years.
(2138)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Oct 19, 2023 8:46am
RE:RE:RE:CYCLIC GLYCOAMINOACID DERIVATIVES
Zero sales in many countries = zero sales
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Oct 19, 2023 7:43am
RE:RE:CYCLIC GLYCOAMINOACID DERIVATIVES
If you go to the main patent, you can see the relatively long list of country and regional patent filings. The number of markets is impressive.
Prev
...
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >